Rare Disease Day Roundup 2022

This past February 28th marked  Rare Disease Day (RDD) 2022, the globally-coordinated movement on rare diseases, which works towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease; the NMD4C would like to take this opportunity to share some of the campaigns and events hosted by members of the neuromuscular community for this year’s event.


 

Muscular Dystrophy Canada

To celebrate RDD MDC hosted an “Individually  Rare, Collectively Common” campaign, spotlighting Canadians affected by different neuromuscular disorders (NMDs) and asking them the question: ‘what do you wish you knew when you were first diagnosed and how have you advocated for yourself along the way?’ Read the responses from Canadians affected by NMDs in this article on MDC’s website!

 

Defeat Duchenne Canada

Defeat Duchenne Canada (formerly Jesse’s Journey) asked for the help of the Duchenne community in raising awareness of Duchenne muscular dystrophy on Rare Disease Day, through their social media campaign. You can see how they raised awareness online by:

  1. Following @defeatduchenne on Facebook, Twitter, Instagram, and LinkedIn
  2. View and share their posts from Monday, February 28th, as Duchenne ambassadors speak to what it’s like living with a rare disease.

 

ProDGNE

To raise awareness for GNE myopathy, the ProDGNE consortium shared a week-long #GNEMfacts campaign in the lead-up to RDD to raise awareness of this ultra rare disease. Curated by communications lead and Patient Representative at Gli Equilibristi HIBM Michela Onali, the campaign shares facts describing the clinical aspects of GNE myopathy, challenges in diagnosis and care, and GNE myopathy research. 

 

Check out the video below to learn more about the ProDGNE consortium, which aims to advance the steps for impactful research in GNE Myopathy by expanding the GNE Myopathy research network and building a long term partnership where patients are central partners and key drivers in Research and Development. You can also visit ProDGNE’s website to learn more. 


 

Myotonic Dystrophy Foundation

The Myotonic Dystrophy Foundation (MDF) is celebrating RDD by continuing their advocacy for people affected Myotonic dystrophy (DM1) to have equal social opportunity, non-discrimination in education and work, and equitable access to health, social care, diagnosis and treatment. MDF have shared a web page where you can access tools to empower advocacy for DM1, learn about possible clinical trials, join the Myotonic Dystrophy Family Registry, and Dm1 guidelines and publications.

This past year MDF recognized the inaugural International  Myotonic Dystrophy Awareness Day on September 15th, in partnership with the members of the global alliance including the NMD4C and MDC. Learn more about MDF’s plans for this year’s event here.

 

 

Facioscapulohumeral muscular dystrophy (FSHD) Society

The FSHD Society have prepared a web page with helpful resources  to join the chorus of FHSD community members telling their story on RDD and beyond, including ways to connect online, joining events, and staying informed by signing up for email updates and following the FSHD blog!

 

Charcot-Marie-Tooth Association

The Charcot-Marie-Tooth (CMT) Association launched a #ImNotGoingToApologizeFor campaign on social media to celebrate RDD. See the campaign below, and learn about how people affected by CMT overcome challenges associated with the disease.

Rare Disease Day logo

Read next...

Ottawa NMD conference poster

Important Deadlines for Ottawa NMD 2023

The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) deadline for discounted early-bird registration and abstract submission is June 30th! 

ENMC mid-career mentoring programme

European Neuromuscular Centre Mid-Career Mentoring Programme Now Open

The European Neuromuscular Centre (ENMC) Mid-Career Mentoring Programme is now open for the third round of mentee candidates!

MNI logo

$6 million Brain Canada grant awarded to McGill to develop virtual integrated patient platform

NMD4C are pleased to share that The Neuro has received a $6 million grant from Brain Canada to fund a new Open Science patient registry to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.

xr:d:DAFhueqzCxw:6,j:3799255692,t:23050201

CIHR Report: What we heard on the future of clinical trials

The Canadian Institute of Health Research (CIHR) have recently released an article outlining the results of their building the future of clinical trials consultation in a What We Heard report.

NBS-2023

New Publication from NMD4C Investigators: Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond

A new study ‘Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond’ examines the differences between provincial newborn screening (NBS) programs and the variability of Spinal muscular atrophy (SMA) screening inclusion within these.

Muscular Dystrophy Canada have announced the nine projects funded through their 2023 research grants competition.

Muscular Dystrophy Canada fund nine new projects through 2023 grant program

Muscular Dystrophy Canada (MDC) recently announced the results of their ‘Neuromuscular Clinical and Translational Research Grant Program’, and we are pleased to celebrate the many NMD4C investigators and members who are leading and supporting projects!